Literature DB >> 1881238

Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.

M Söderberg1, C Edlund, K Kristensson, G Dallner.   

Abstract

The two major phospholipid classes, namely, phosphatidylethanolamines (PE) and phosphatidylcholines (PC), were studied in four different regions of human brain, i.e., in frontal gray matter, frontal white matter, hippocampus and in pons. The fatty acid (FA) compositions of these phospholipids were found to be specific for the different regions. PC contains mostly saturated and 18:1 FA, while PE is rich in polyunsaturated FA. Aging has no influence on the FA compositions, while in Alzheimer's disease (AD) PE is modified in all four regions, particularly in frontal gray matter and in hippocampus. The abundance of the major monounsaturated FA of PE, 18:1, is not significantly altered in Alzheimer's disease, but there is a substantial increase in the relative amounts of the saturated components 14:0, 16:0 and 18:0. This is paralleled by a decrease in the polyunsaturated FA 20:4, 22:4 and 22:6. It is not clear whether the changes observed are specific for AD. Changes in saturated/polyunsaturated FA ratio are likely to influence cellular function, which in turn may cause certain neural deficiencies. The findings do not support the hypothesis that AD reflects an accelerated aging process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1881238     DOI: 10.1007/bf02536067

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Disposition of proteins and aminophospholipids in the sarcoplasmic reticulum membrane.

Authors:  C Hidalgo; N Ikemoto
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

2.  Spin labels as enzyme substrates. Heterogeneous lipid distribution in liver microsomal membranes.

Authors:  A Stier; E Sackmann
Journal:  Biochim Biophys Acta       Date:  1973-07-06

Review 3.  Organisation of proteins in membranes with special reference to the cytochrome oxidase system.

Authors:  G Vanderkooi
Journal:  Biochim Biophys Acta       Date:  1974-12-16

4.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

Review 5.  The biosynthesis of unsaturated fatty acids and its control in mammalian liver.

Authors:  R Jeffcoat
Journal:  Essays Biochem       Date:  1979       Impact factor: 8.000

6.  Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease.

Authors:  B W Brooksbank; M Martinez
Journal:  Mol Chem Neuropathol       Date:  1989-12

7.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

8.  Lipid compositions of different regions of the human brain during aging.

Authors:  M Söderberg; C Edlund; K Kristensson; G Dallner
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

9.  The preference of cholesterol for phosphatidylcholine in mixed phosphatidylcholine-phosphatidylethanolamine bilayers.

Authors:  P W Van Dijck; B De Kruijff; L L Van Deenen; J De Gier; R A Demel
Journal:  Biochim Biophys Acta       Date:  1976-12-02

10.  Compartmentalization of phosphatidylethanolamine in microsomal membranes from rat liver.

Authors:  C Valtersson; G Dallner
Journal:  J Lipid Res       Date:  1982-08       Impact factor: 5.922

View more
  155 in total

1.  Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.

Authors:  Nurit Hadad; Rachel Levy
Journal:  Neuromolecular Med       Date:  2017-08-04       Impact factor: 3.843

2.  A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

Authors:  Walter J Lukiw; Jian-Guo Cui; Victor L Marcheselli; Merete Bodker; Anja Botkjaer; Katherine Gotlinger; Charles N Serhan; Nicolas G Bazan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Neurometabolic roles of ApoE and Ldl-R in mouse brain.

Authors:  Jieun Lee; Joseph Choi; G William Wong; Michael J Wolfgang
Journal:  J Bioenerg Biomembr       Date:  2015-12-21       Impact factor: 2.945

4.  Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease.

Authors:  M A Bradley; W R Markesbery; M A Lovell
Journal:  Free Radic Biol Med       Date:  2010-02-18       Impact factor: 7.376

5.  The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding.

Authors:  Sarah K Orr; Jasmin Y M Tong; Jing X Kang; David W L Ma; Richard P Bazinet
Journal:  Neurochem Res       Date:  2010-02-23       Impact factor: 3.996

6.  Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats.

Authors:  Miki Igarashi; Fei Gao; Hyung-Wook Kim; Kaizong Ma; Jane M Bell; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2008-11-27

7.  Higher serum EPA or DHA, and lower ARA compositions with age independent fatty acid intake in Japanese aged 40 to 79.

Authors:  Rei Otsuka; Yuki Kato; Tomoko Imai; Fujiko Ando; Hiroshi Shimokata
Journal:  Lipids       Date:  2013-02-07       Impact factor: 1.880

8.  Activation and reversal of lipotoxicity in PC12 and rat cortical cells following exposure to palmitic acid.

Authors:  Frankis G Almaguel; Jo-Wen Liu; Fabio J Pacheco; Carlos A Casiano; Marino De Leon
Journal:  J Neurosci Res       Date:  2009-04       Impact factor: 4.164

9.  Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.

Authors:  Thomas Fraser; Hannah Tayler; Seth Love
Journal:  Neurochem Res       Date:  2009-11-11       Impact factor: 3.996

Review 10.  Omega-3 fatty acids and cognitive function in women.

Authors:  Jennifer G Robinson; Nkechinyere Ijioma; William Harris
Journal:  Womens Health (Lond)       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.